Literature DB >> 21489582

Association of serum ferritin with metabolic syndrome and diabetes mellitus in the South Korean general population according to the Korean National Health and Nutrition Examination Survey 2008.

Byung-Kook Lee1, Yangho Kim, Young-Il Kim.   

Abstract

We examined the association of serum ferritin levels with metabolic syndrome (MS) and diabetes mellitus in a representative sample of the adult South Korean population using data from the 2008 Korean National Health and Nutrition Examination Survey. We conducted a cross-sectional study of 6311 adults older than 20 years who participated in the 2008 Korean National Health and Nutrition Examination Survey. Metabolic syndrome was defined as the presence of at least 3 of the following: elevated blood pressure, low high-density lipoprotein cholesterol, elevated serum triglycerides, elevated plasma glucose, and abdominal obesity. Diabetes mellitus was defined as fasting glucose of at least 126 mg/dL. Insulin resistance was determined using the homeostasis model assessment estimate of insulin resistance. In a representative sample of the adult Korean population, MS was more prevalent in the highest quartile compared with the lowest quartile of serum ferritin concentrations in women following adjustments for age, education, smoking, alcohol intake, body mass index, aspartate aminotransferase, and alanine aminotransferase. Diabetes mellitus was more prevalent in the highest quartile compared with the lowest quartile of serum ferritin concentrations in premenopausal women and men. The geometric means of fasting insulin and insulin resistance determined using the homeostasis model assessment of insulin resistance in the fourth serum ferritin quartiles of postmenopausal women and men were significantly higher compared with those in the first quartile of the respective groups. The present study demonstrates that elevated serum ferritin concentrations are associated with an increased risk of MS and diabetes mellitus in a representative sample of the adult South Korean population.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21489582     DOI: 10.1016/j.metabol.2011.02.008

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  33 in total

Review 1.  Red meat, dietary heme iron, and risk of type 2 diabetes: the involvement of advanced lipoxidation endproducts.

Authors:  Desley L White; Avril Collinson
Journal:  Adv Nutr       Date:  2013-07-01       Impact factor: 8.701

2.  Fasting serum levels of ferritin are associated with impaired pancreatic beta cell function and decreased insulin sensitivity: a population-based study.

Authors:  Linéa Bonfils; Christina Ellervik; Nele Friedrich; Allan Linneberg; Camilla H Sandholt; Marit E Jørgensen; Torben Jørgensen; Torben Hansen; Oluf Pedersen; Kristine H Allin
Journal:  Diabetologia       Date:  2014-12-14       Impact factor: 10.122

3.  The association between higher serum ferritin level and lower bone mineral density is prominent in women ≥45 years of age (KNHANES 2008-2010).

Authors:  B-J Kim; S H Lee; J-M Koh; G S Kim
Journal:  Osteoporos Int       Date:  2013-04-17       Impact factor: 4.507

4.  Association of Multiple Biomarkers of Iron Metabolism and Type 2 Diabetes: The EPIC-InterAct Study.

Authors:  Clara Podmore; Karina Meidtner; Matthias B Schulze; Robert A Scott; Anna Ramond; Adam S Butterworth; Emanuele Di Angelantonio; John Danesh; Larraitz Arriola; Aurelio Barricarte; Heiner Boeing; Françoise Clavel-Chapelon; Amanda J Cross; Christina C Dahm; Guy Fagherazzi; Paul W Franks; Diana Gavrila; Sara Grioni; Marc J Gunter; Gaelle Gusto; Paula Jakszyn; Verena Katzke; Timothy J Key; Tilman Kühn; Amalia Mattiello; Peter M Nilsson; Anja Olsen; Kim Overvad; Domenico Palli; J Ramón Quirós; Olov Rolandsson; Carlotta Sacerdote; Emilio Sánchez-Cantalejo; Nadia Slimani; Ivonne Sluijs; Annemieke M W Spijkerman; Anne Tjonneland; Rosario Tumino; Daphne L van der A; Yvonne T van der Schouw; Edith J M Feskens; Nita G Forouhi; Stephen J Sharp; Elio Riboli; Claudia Langenberg; Nicholas J Wareham
Journal:  Diabetes Care       Date:  2016-02-09       Impact factor: 19.112

5.  Effect of HFE Gene Mutation on Changes in Iron Metabolism Induced by Nordic Walking in Elderly Women.

Authors:  Jakub Kortas; Ewa Ziemann; Jedrzej Antosiewicz
Journal:  Clin Interv Aging       Date:  2020-05-13       Impact factor: 4.458

Review 6.  Body iron stores and heme-iron intake in relation to risk of type 2 diabetes: a systematic review and meta-analysis.

Authors:  Zhuoxian Zhao; Sheyu Li; Guanjian Liu; Fangfang Yan; Xuelei Ma; Zeyu Huang; Haoming Tian
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

7.  Association of serum ferritin and the development of metabolic syndrome in middle-aged Korean men: a 5-year follow-up study.

Authors:  Sung Keun Park; Jae-Hong Ryoo; Min-Gi Kim; Ju-Young Shin
Journal:  Diabetes Care       Date:  2012-08-28       Impact factor: 19.112

8.  Soluble transferrin receptor levels are positively associated with insulin resistance but not with the metabolic syndrome or its individual components.

Authors:  Milton Fabian Suárez-Ortegón; Stela McLachlan; Sarah H Wild; José Manuel Fernández-Real; Caroline Hayward; Ozren Polašek
Journal:  Br J Nutr       Date:  2016-09-08       Impact factor: 3.718

9.  Iron metabolism is associated with adipocyte insulin resistance and plasma adiponectin: the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study.

Authors:  Nick Wlazlo; Marleen M J van Greevenbroek; Isabel Ferreira; Eugene H J M Jansen; Edith J M Feskens; Carla J H van der Kallen; Casper G Schalkwijk; Bert Bravenboer; Coen D A Stehouwer
Journal:  Diabetes Care       Date:  2012-09-06       Impact factor: 19.112

10.  Metabolic syndrome and hemoglobin levels in elderly adults: the Invecchiare in Chianti Study.

Authors:  Alice Laudisio; Stefania Bandinelli; Antonella Gemma; Luigi Ferrucci; Raffaele Antonelli Incalzi
Journal:  J Am Geriatr Soc       Date:  2013-05-06       Impact factor: 7.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.